Home / Central Data Catalog / FRESH-PEF72-EN
central

An observational study of olanzapine coated and orodispersible tablets effectiveness in schizophrenic and bipolar outpatients

France, Germany, Greece, 2007 - 2009
Reference ID
FRESH-PEF72-en
Metadata
DDI/XML JSON
Study website Interactive tools
Created on
Feb 18, 2026
Last modified
Feb 18, 2026
Page views
56
  • Identification
  • Scope
  • Coverage
  • Producers and sponsors
  • Study authorization
  • Sampling
  • Survey instrument
  • Data collection
  • Study activities
  • Data Access

    • Identification

    Survey ID number

    FRESH-PEF72-en
    Title

    An observational study of olanzapine coated and orodispersible tablets effectiveness in schizophrenic and bipolar outpatients
    Abbreviation or Acronym

    ZEN
    Country
    Name Country code
    France fr
    Germany de
    Greece gr
    Kind of Data

    ['Clinical data','Participant-reported health data']
    Unit of Analysis

    Individuals

    Scope

    Topics
    Topic Vocabulary
    Neurology health theme
    Psychiatry health theme
    Behavioral determinants health determinant
    Healthcare system determinants: Use of care health determinant
    Healthcare system determinants health determinant
    Keywords
    bipolar disorders olanzapine and duration of treatment Schizophrenia

    Coverage

    Universe

    {"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"Patients aged 18 years and older, - suffering from bipolar disorders or schizophrenic disorders according to DSM-IV criteria, - initiating or having initiated a treatment via olanzapine in tablet or orodispersible form.","clusion_E":""}

    Producers and sponsors

    Producers
    Name Role
    LILLY FRANCE sponsor
    Funding Agency/Sponsor
    Name
    AGENCE NATIONALE DE RECHERCHES SUR LE SIDA ET LES HEPATITES VIRALES (ANRS MIE)

    Study authorization

    Agency
    Agency name
    CNIL

    Sampling

    Sample frame

    Unit Type

    ['Through independent healthcare practitioners']
    Sampling Procedure

    ['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']

    Survey instrument

    Questionnaires

    Access on specific project only
    Methodology notes

    Observational Study

    Data collection

    Dates of Data Collection
    Start End
    2007-01-01 2009-01-01
    Mode of data collection
    • {"concept":{"vocabURI":"Interview","vocab":"CESSDA"},"value":"Interview with the participant (including clinical)"}

    Study activities

    Study activities
    Type
    primary evaluation
    Description
    Health event/morbidity Quality of life/health perception Others

    Data Access

    Availability Status

    {"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}
    Back to Catalog